Contract EPB12D00035
Experimental Pathology Laboratories, Inc. · Environmental Protection Agency · March 16, 2012
Experimental Pathology Laboratories, Inc. was awarded a federal contract by Environmental Protection Agency on March 16, 2012 for $9,000 of work in research and development in biotechnology. Performance is in Sterling, VA. This is a task or delivery order issued under parent IDIQ EP08D000730. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- EPB12D00035
- Parent IDIQ
- EP08D000730
- Award type
- Bpa
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- R&D- Other Research And Development (Basic Research)
- Place of performance
- Sterling, VA
- First action
- March 16, 2012
Description
HISTOLOGY SERVICES
Modification timeline
-
March 16, 2012Base award$9.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Westat, Inc. | Environmental Protection Agency | August 20, 2025 | $2.64M |
| University Of Florida | Environmental Protection Agency | September 13, 2024 | $21.4K |
| Michigan State University | Environmental Protection Agency | September 29, 2020 | $95.0K |
| Board Of Regents Of Nevada System Of Higher Education | Environmental Protection Agency | August 30, 2011 | $119.8K |
| Myriad Rbm, Inc. | Environmental Protection Agency | August 29, 2011 | $0 |
| Cincinnati Univ Of | Environmental Protection Agency | August 24, 2011 | $0 |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Alliance For Energy Innovation, Llc | 2 | $10.68B |
| 2 | Emergent Product Development Gaithersburg Inc. | 7 | $1.63B |
| 3 | Janssen Pharmaceuticals, Inc. | 2 | $1.05B |
| 4 | Regeneron Pharmaceuticals Inc | 4 | $1.01B |
| 5 | Siga Technologies, Inc. | 3 | $560.59M |
| 6 | Battelle National Biodefense Institute, Llc | 106 | $469.31M |
| 7 | Glaxosmithkline, Llc | 6 | $321.65M |
| 8 | Merck Sharp & Dohme Llc | 3 | $309.72M |
| 9 | Sri International | 130 | $258.61M |
| 10 | American Type Culture Collection | 7 | $243.18M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract EPB12D00035?
Contract EPB12D00035 is a federal contract awarded to Experimental Pathology Laboratories, Inc. by Environmental Protection Agency on March 16, 2012 for $9,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 0 times since the base award.
Who won contract EPB12D00035?
Experimental Pathology Laboratories, Inc. won contract EPB12D00035 from Environmental Protection Agency.
How much is contract EPB12D00035 worth?
Contract EPB12D00035 has obligated $9,000 to date.